Stock Events

Regeneron Pharmaceuticals (REGN) Q4 2021 Earnings

4NovConfirmed
Q1 2021
Q2 2021
Q3 2021
Q4 2021
8.47
14.25
20.02
25.8

Details

Expected EPS
10.8
Actual EPS
14.37
Surprise EPS
3.57
Surprise Percent
+33.06%

Description

Regeneron Pharmaceuticals (REGN) has reported earnings of 14.37 per share for Q4 2021.

0 Comments

Share your thoughts